133 related articles for article (PubMed ID: 25594199)
1. Repurposing mebendazole for the treatment of medulloblastoma.
Bodhinayake I; Symons M; Boockvar JA
Neurosurgery; 2015 Feb; 76(2):N15-6. PubMed ID: 25594199
[No Abstract] [Full Text] [Related]
2. Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis.
Bai RY; Staedtke V; Rudin CM; Bunz F; Riggins GJ
Neuro Oncol; 2015 Apr; 17(4):545-54. PubMed ID: 25253417
[TBL] [Abstract][Full Text] [Related]
3. Perspectives: Chemotherapy of medulloblastoma.
Mastrangelo S; Tornesello A; Mastrangelo R
Med Pediatr Oncol; 1999 Aug; 33(2):116-9. PubMed ID: 10398188
[No Abstract] [Full Text] [Related]
4. [High risk cerebellar medulloblastoma: the use of high doses of chemotherapy].
Benito Bernal A; Villa Alcázar M; Díaz Pérez MA; Madero López L
An Esp Pediatr; 1997 Dec; 47(6):647-50. PubMed ID: 9575128
[No Abstract] [Full Text] [Related]
5. Medulloblastoma: need for targeted treatment.
Luttjeboer M; Kaspers GJ
Expert Rev Anticancer Ther; 2006 May; 6(5):649-52. PubMed ID: 16759156
[No Abstract] [Full Text] [Related]
6. Management of late extraneural recurrence of medulloblastoma without high-dose chemotherapy.
Phillips RE; Curran KJ; Khakoo Y
J Neurooncol; 2015 Sep; 124(3):523-4. PubMed ID: 26115616
[No Abstract] [Full Text] [Related]
7. High-dose chemotherapy for recurrent medulloblastoma: time for a reappraisal.
Gajjar A
Cancer; 2008 Apr; 112(8):1643-5. PubMed ID: 18306390
[No Abstract] [Full Text] [Related]
8. Letter: CCNU in teatment of recurrent medulloblastoma.
Ward HW
Br Med J; 1974 Mar; 1(5908):642. PubMed ID: 4206861
[No Abstract] [Full Text] [Related]
9. Medulloblastoma--caution regarding new treatment approaches.
Kun LE; Constine LS
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):897-9. PubMed ID: 2004969
[No Abstract] [Full Text] [Related]
10. Blockade of estrogen receptor signaling to improve outlook for medulloblastoma sufferers.
Belcher SM
Future Oncol; 2009 Aug; 5(6):751-4. PubMed ID: 19663723
[No Abstract] [Full Text] [Related]
11. Drug Repurposing in Medulloblastoma: Challenges and Recommendations.
Hammoud H; Saker Z; Harati H; Fares Y; Bahmad HF; Nabha S
Curr Treat Options Oncol; 2020 Nov; 22(1):6. PubMed ID: 33245404
[TBL] [Abstract][Full Text] [Related]
12. SHH inhibitors for the treatment of medulloblastoma.
Samkari A; White J; Packer R
Expert Rev Neurother; 2015; 15(7):763-70. PubMed ID: 26027634
[TBL] [Abstract][Full Text] [Related]
13. Early and persisting response to vismodegib in a patient with bone metastasizing medulloblastoma.
Asklund T; Henriksson R; Axelsson J; Bergström Å; Kasper M; Ögren M; Toftgård R; Riklund KÅ
Acta Oncol; 2013 May; 52(4):862-6. PubMed ID: 23013267
[No Abstract] [Full Text] [Related]
14. Amifostine protects against cisplatin-induced nephrotoxicity in a child with medulloblastoma.
Hayek M; Srinivasan A
Pediatr Hematol Oncol; 2003; 20(3):253-6. PubMed ID: 12637222
[No Abstract] [Full Text] [Related]
15. Clinical management of medulloblastoma in adults.
Eisenstat DD
Expert Rev Anticancer Ther; 2004 Oct; 4(5):795-802. PubMed ID: 15485314
[TBL] [Abstract][Full Text] [Related]
16. Targeted Therapy Makes Inroads in Medulloblastoma.
Schmidt C
J Natl Cancer Inst; 2015 Nov; 107(11):djv353. PubMed ID: 26538622
[No Abstract] [Full Text] [Related]
17. Medulloblastoma drugs in development: Current leads, trials and drawbacks.
Wen J; Hadden MK
Eur J Med Chem; 2021 Apr; 215():113268. PubMed ID: 33636537
[TBL] [Abstract][Full Text] [Related]
18. Medulloblastoma growth inhibition by hedgehog pathway blockade.
Berman DM; Karhadkar SS; Hallahan AR; Pritchard JI; Eberhart CG; Watkins DN; Chen JK; Cooper MK; Taipale J; Olson JM; Beachy PA
Science; 2002 Aug; 297(5586):1559-61. PubMed ID: 12202832
[TBL] [Abstract][Full Text] [Related]
19. [Role of adjuvant chemotherapy in the treatment of medulloblastoma in children].
Sachivko NV; Konoplia NE; Petrovich SV; Sharak EV
Vopr Onkol; 2002; 48(3):318-21. PubMed ID: 12455354
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa.
Packer RJ
Ann Neurol; 1990 Dec; 28(6):823-8. PubMed ID: 2178331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
